BioLamina

BioLamina develops and manufactures full-length human recombinant laminins, marketed as Biolaminin, which serve as biologically relevant matrices for 2D and 3D cell culture. These products provide a defined, animal-origin-free environment for stem cell processes, differentiation, and maturation of specialized cell types like hepatocytes and cardiomyocytes. The company serves researchers and clinical developers in the fields of cell therapy, disease modeling, and therapeutic discovery.